Cargando…

Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms

BACKGROUND: In vitro drug susceptibility testing of malaria parasites remains an important component of surveillance for anti-malarial drug resistance. The half-maximal inhibition of growth (IC(50)) is the most commonly reported parameter expressing drug susceptibility, derived by a variety of stati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wirjanata, Grennady, Handayuni, Irene, Zaloumis, Sophie G., Chalfein, Ferryanto, Prayoga, Pak, Kenangalem, Enny, Poespoprodjo, Jeanne Rini, Noviyanti, Rintis, Simpson, Julie A., Price, Ric N., Marfurt, Jutta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776429/ https://www.ncbi.nlm.nih.gov/pubmed/26935745 http://dx.doi.org/10.1186/s12936-016-1173-1

Ejemplares similares

Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry
por: Wirjanata, Grennady, et al.
Publicado: (2015)

Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes
por: Wirjanata, Grennady, et al.
Publicado: (2017)

Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility
por: Pava, Zuleima, et al.
Publicado: (2015)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
por: Marfurt, Jutta, et al.
Publicado: (2021)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
por: Pava, Zuleima, et al.
Publicado: (2020)

Passively versus Actively Detected Malaria: Similar Genetic Diversity but Different Complexity of Infection
por: Pava, Zuleima, et al.
Publicado: (2017)

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
por: Pava, Zuleima, et al.
Publicado: (2016)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life
por: Burdam, Faustina Helena, et al.
Publicado: (2016)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection
por: Kho, Steven, et al.
Publicado: (2016)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
por: Kenangalem, Enny, et al.
Publicado: (2019)

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections
por: Pava, Zuleima, et al.
Publicado: (2017)

Therapeutic Response to Dihydroartemisinin–Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2018)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
por: Leonardo, Leo, et al.
Publicado: (2022)

Effective Preparation of Plasmodium vivax Field Isolates for High-Throughput Whole Genome Sequencing
por: Auburn, Sarah, et al.
Publicado: (2013)

An Analytical Method for Assessing Stage-Specific Drug Activity in Plasmodium vivax Malaria: Implications for Ex Vivo Drug Susceptibility Testing
por: Kerlin, Douglas H., et al.
Publicado: (2012)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
por: Kenangalem, Enny, et al.
Publicado: (2016)

Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study
por: Langford, Siobhan, et al.
Publicado: (2015)

Case Report: Severe Plasmodium vivax Malaria after Splenectomy
por: Kambuaya, Noy Norman, et al.
Publicado: (2023)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2017)

Chloroquine Resistant Plasmodium vivax: In Vitro Characterisation and Association with Molecular Polymorphisms
por: Suwanarusk, Rossarin, et al.
Publicado: (2007)

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
por: Dini, Saber, et al.
Publicado: (2020)

Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia
por: Devine, Angela, et al.
Publicado: (2018)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2020)

High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malaria
por: Ioannidis, Lisa J., et al.
Publicado: (2021)

Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2014)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia
por: Douglas, Nicholas M, et al.
Publicado: (2014)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
por: Rahmalia, Annisa, et al.
Publicado: (2023)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia
por: Kho, Steven, et al.
Publicado: (2019)

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
por: Karyana, Muhammad, et al.
Publicado: (2016)

Impacts of tuberculosis services strengthening and the COVID-19 pandemic on case detection and treatment outcomes in Mimika District, Papua, Indonesia: 2014–2021
por: Lestari, Trisasi, et al.
Publicado: (2022)

Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics
por: Auburn, Sarah, et al.
Publicado: (2018)

Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia
por: Lampah, Daniel A., et al.
Publicado: (2015)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study
por: Kho, Steven, et al.
Publicado: (2021)

Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Early and late mortality after malaria in young children in Papua, Indonesia
por: Patriani, Dewi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9fjmjbvd9o2lorc5svtbgi3pkn